UBS analyst Karl Keirstead raised the firm’s price target on Veeva (VEEV) to $220 from $200 and keeps a Neutral rating on the shares. Veeva posted solid growth for Q4, but guidance for fiscal 2027 was mixed, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva price target raised to $215 from $205 at Morgan Stanley
- Veeva price target raised to $245 from $212 at Stifel
- Veeva price target raised to $235 from $200 at Canaccord
- Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva
- Veeva price target lowered to $317 from $333 at Wells Fargo